Shanghai First People's Hospital
USPTO PatentsView assignee record - 6 granted patents across 3 technology areas, recorded in grant years 2015–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).
The verdict
According to USPTO PatentsView, Shanghai ranks #42,931 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 3 technology areas.
- #42,931
- of 49,997 US assignees by volume
- 14th percentile
- by Innovation Score (24.1/100)
- 7.7
- avg claims per patent
- -80%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R42931 · Foreign Corporation #42,931 · 6 grants
GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-SPARSE · TYPE-FRNCORP · VEL-DROP · BOOK-FULL
- GRANTS-MICRO 6 grants
- LOWER-Q #42,931/49,997
- PHOTO-FINISH Shandong NHU…
- CPC-NARROW C07K · 3 areas
- INNOV-THIN 24.1/100
- CLAIMS-SPARSE 7.7 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-DROP -80% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Shandong NHU Pharmaceutical Co., Ltd. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Shanghai’s 24.1 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Shanghai
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- MavorCo Operations · near 24
MavorCo Operations · near
24 score
- Shanghai First… · this assignee 24
Shanghai First… · this assignee
24 score
- Semicon Light · near 24
Semicon Light · near
24 score
- Delta Valve · near 24
Delta Valve · near
24 score
- On Point Ball Marker · near 24
On Point Ball Marker · near
24 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Shanghai's Innovation Score is 24.1/100 (14th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Shanghai?
Each dot is one of Shanghai’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Shanghai’s own 7.7 claims/patent is at or below the 11.7 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Shanghai's grants concentrate
Shanghai First People's Hospital is a focused PatentsView assignee: 3 CPC subclasses with 100% of grants classified under C07K (Peptides). Peak complete grant year is 2015 (2 grants) versus a trough of 1 in 2016. By volume, Shanghai sits between Shandong NHU Pharmaceutical Co., Ltd. and Shanghai Institute OF Technology.
Shanghai's three-year grant acceleration
Shanghai First People's Hospital shows 1 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Shanghai's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Shandong NHU Phar…
Shandong NHU Pharmaceutical Co., Ltd.
6 patents
- Shandong Zhonghai…
Shandong Zhonghai Pharmaceutical Co. Ltd
6 patents
- Shang HAI PAN SHI…
Shang HAI PAN SHI TOU ZI Guan LI YOU Xian Gong SI
6 patents
- Shanghai Eastsoft…
Shanghai Eastsoft Microelectronics Co., Ltd.
6 patents
- Shanghai Henlius…
Shanghai Henlius Biotech, Inc.
6 patents
- Shanghai Highly E…
Shanghai Highly Electrical Appliances Co., Ltd.
6 patents
- Shanghai Industri…
Shanghai Industrial μ Technology Research Institute
6 patents
- Shanghai Institut…
Shanghai Institute OF Technology
6 patents
- Shanghai First Pe… ◀
Shanghai First People's Hospital
6 patents
What this shows Shanghai holds 6 patents at rank #42,814, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Shanghai
By rank, the assignees closest to #42,814 in granted patent volume.
- Shandong NHU Pharmaceutical Co., Ltd. #42,810 · 6 patents
- Shandong Zhonghai Pharmaceutical Co. Ltd #42,811 · 6 patents
- Shang HAI PAN SHI TOU ZI Guan LI YOU Xian Gong SI #42,812 · 6 patents
- Shanghai Eastsoft Microelectronics Co., Ltd. #42,813 · 6 patents
- Shanghai Henlius Biotech, Inc. #42,815 · 6 patents
- Shanghai Highly Electrical Appliances Co., Ltd. #42,816 · 6 patents
- Shanghai Industrial μ Technology Research Institute #42,817 · 6 patents
- Shanghai Institute OF Technology #42,818 · 6 patents
Leaders in C07K (Peptides)
Other assignees with the most granted patents in Shanghai's primary technology class.
- The Regents of the University of California 894 in class
- Regeneron Pharmaceuticals, Inc. 824 in class
- Immatics Biotechnologies GmbH 678 in class
- Genentech, Inc. 565 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 513 in class
- The Trustees of the University of Pennsylvania 501 in class
- Novartis AG 407 in class
- The Board of Trustees of the Leland Stanford Junior University 400 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Shanghai, neither rank-band nor same-CPC leaders (those blocks stay above). In C07K (Peptides), Shanghai ranks #1,362 of 3,615 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (24 here).
Shanghai's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
24 14th percentile higher than 14% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 33.3% |
| 2016 | 1 | 16.7% |
| 2017 | 1 | 16.7% |
| 2019 | 1 | 16.7% |
| 2022 | 1 | 16.7% |
Which technologies does Shanghai First People's Hospital patent most?
Top 3 of 3 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Shanghai First People's Hospital's patent record in context - here's where to go next.
- Shanghai First People's Hospital's lead technology class is C07K (Peptides), 100% of its portfolio - see every assignee active in that class. Explore C07K
- Ranked #42,931 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Shanghai First People's Hospital against Shandong NHU Pharmaceutical Co., Ltd., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 24.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.